55 studies found for:    dermatomyositis
Show Display Options
RSS Create an RSS feed from your search for:
dermatomyositis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis
Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM));   Drug: Sodium thiosulfate
2 Completed Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Immunosuppressive Agents
3 Active, not recruiting Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: Prednisone;   Drug: Methotrexate
4 Completed Methimazole to Treat Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: methimazole
5 Completed Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: h5G1.1-mAb
6 Unknown  Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Conditions: Myositis;   Dermatomyositis;   Polymyositis;   Juvenile Dermatomyositis
Interventions: Drug: Rituximab;   Drug: Placebo
7 Recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
8 Completed Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: GB-0998;   Drug: Placebo of GB-0998
9 Not yet recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: Placebo
10 Terminated Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Prednisone;   Drug: Methotrexate;   Drug: Etanercept
11 Completed Hand Function in Patients With Poly- or Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention:
12 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX
13 Completed
Has Results
A Pilot Study of Etanercept in Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Etanercept;   Drug: Placebo
14 Unknown  Abatacept Treatment in Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Abatacept
15 Unknown  Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Other: Active rehabilitation
16 Completed Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
Conditions: Vasculitis, Hypersensitivity;   Connective Tissue Diseases;   Dermatomyositis;   Vasculitis
Interventions: Drug: Methylprednisolone;   Drug: Prednisolone
17 Recruiting Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312
18 Unknown  A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: Apremilast
19 Terminated Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Interventions: Drug: BAF312;   Drug: Placebo
20 Completed Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Infliximab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years